An extended-release composition comprising a somatostatin derivative in microparticles

Details for Australian Patent Application No. 2008252931 (hide)

Owner Novartis AG

Inventors Lambert, Olivier; Vucenovic, Vitomir; Riemenschnitter, Marc

Agent Davies Collison Cave

Pub. Number AU-B-2008252931

PCT Pub. Number WO2008/142153

Priority 07108796.9 24.05.07 EP

Filing date 23 May 2008

Wipo publication date 27 November 2008

Acceptance publication date 1 September 2011

International Classifications

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/142153 Priority application(s): WO2008/142153

1 September 2011 Application Accepted

  Published as AU-B-2008252931

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008252932-Appliance for conditioning a milk-based liquid

2008252925-Combination comprising pyrrolidone5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis